These results together with those showing the astemizole-dependant downregulation of CYP24A1 gene expression, involved in calcitriol inactivation, in breast cancer cells, provided further evidence to explain the increased antiproliferative activity of calcitriol in the presence of astemizole. The gene discussed is CYP24A1; the disease is breast cancer.